2016
- Joint letter to the Review of the Research & Development Tax Incentive MA Submission (Mar 2016) Friday, 29 January 2021
- Submission to the Public Consultation on the draft revised Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines (Draft Version 5.0) (5 April) Friday, 29 January 2021
- Submission to the Public Consultation on the draft chapter “Product Type 4 – Hybrid Technologies and Co-dependent Technologies” of the draft revised Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines (Draft Version 5.0) (11 April) Friday, 29 January 2021
- Joint Submission to the Public Consultation on the Draft Terms of Reference for the Post-Market Review of Ezetimibe and Chronic Obstructive Pulmonary Disease (COPD) Medicines (22 April) Friday, 29 January 2021
- Submission to the Productivity Commission Review of Intellectual Property Arrangements Draft Report (7 June) Friday, 29 January 2021
- Submission to Senate Inquiry into the Omnibus Bill 2016 (10 September) Friday, 29 January 2021
- Review of Pharmacy Remuneration and Regulation Discussion Paper (23 September) Friday, 29 January 2021
- R&D Tax incentive Review Report Consultation 2016 (31 October) Friday, 29 January 2021
- Submission to the Senate Standing Committee on Foreign Affairs, Defence and Trade References Inquiry into the Trans-Pacific Partnership Agreement (3 November) Friday, 29 January 2021
- Response to TGA’s Consultation Paper on Orphan Drug Medicines (29 November) Friday, 29 January 2021
- Medicines and Medical Devices Review – Response to TGA’s consultation paper 2016 on Expedited Pathways (19 December) Friday, 29 January 2021
- Medicines and Medical Devices Review – Response to TGA’s consultation paper 2016 on Comparable Overseas Regulators (19 December) Friday, 29 January 2021
- Submission to the 2016-17 Federal Government Budget (8 February) Monday, 8 February 2016